 "Covaxin")
Bharat Biotech’s Covid-19 vaccine Covaxin neutralises multiple variants of SARS-CoV-2 and effectively works against the double mutant strain as well, said the Indian Council of Medical Research (ICMR) on Wednesday.
In a tweet from its official handle, the ICMR said, “ICMR study shows Covaxin neutralises against multiple variants of SARS-CoV-2 and effectively neutralises the double mutant strain as well.” It added: “Covaxin has been found to effectively neutralise the double mutant strain as well.”
The B.1.617 or ‘double mutant” Indian variant carries two mutations, including the L452R and E484Q, which have been seen separately before in other variants
In a tweet from its official handle, the ICMR said, “ICMR study shows Covaxin neutralises against multiple variants of SARS-CoV-2 and effectively neutralises the double mutant strain as well.” It added: “Covaxin has been found to effectively neutralise the double mutant strain as well.”
The B.1.617 or ‘double mutant” Indian variant carries two mutations, including the L452R and E484Q, which have been seen separately before in other variants
